As Chief Matchmaker, I recently had the pleasure of speaking with Beth Fleck, Director of In Vitro Pharmacology Mark:  “Beth, why did you decide to join Crinetics?” Beth:  “Yes.  There are a lot of learning opportunities at Crinetics.  Mark:  “Beth, why would someone want you as their boss?” Beth:  “Well, I enjoy training and mentoring team members. 

Mark recently discussed this exciting opportunity with Beth Fleck, Director of In Vitro Pharmacology

Our Chief Matchmaker, Mark Schmeizl, had a great conversation about this position with Beth Fleck, Director

But when Beth Fleck measured dissociation rates of the CRF receptor radioligands, the compound that worked

Marshall, the throughline is personal: she remembers the exact lecture at Bath where she first heard The moment baclofen activated ion channels in Xenopus oocytes expressing both — with Dr. mic Selected Quotes "We did the classic experiment in Xenopus oocytes, where you inject the cDNA of both About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor in the heart is activated by adrenaline, during her undergraduate studies at Bath University

Arun Shukla on how two beta-arrestin isoforms regulate over 800 receptors, why "non-canonical" GPCRs information from NMR and hydrogen-deuterium exchange, and custom-engineered antibody fragments that both beta-arrestin-biased receptors Engineered antibody fragments as tools for structural stabilization and Shukla's lab is also one of the field's oldest open questions: how do just two beta-arrestin isoforms Shukla's lab and others have shown they signal robustly through beta-arrestins — which makes them, in